BIAF — BioAffinity Technologies Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
- $27.29m
- $25.67m
- $2.53m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -7.27 | -6.33 | -8.15 | -7.94 |
Depreciation | ||||
Non-Cash Items | 4.56 | 3.64 | 3.96 | 0.749 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.483 | 0.633 | 0.114 | 0.901 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Cash from Operating Activities | -2.21 | -2.05 | -4.07 | -6.04 |
Capital Expenditures | -0.003 | 0 | -0.22 | -0.023 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | — | — | — | -2.19 |
Acquisition of Business | ||||
Cash from Investing Activities | -0.003 | 0 | -0.22 | -2.21 |
Financing Cash Flow Items | 0 | -0.181 | -0.056 | — |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 1.72 | 3.33 | 14.3 | -0.345 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -0.495 | 1.28 | 10.1 | -8.59 |